Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 7, 1999, Pages 1695-1699

  Rohde, Luis E P ^b   Arroyo, Luis H ^b   Rifai, Nader ^b   Creager, Mark A ^b   Libby, Peter ^b   Ridker, Paul M ^b   Lee, Richard T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Aortic aneurysm; Atherosclerosis; Homocysteine; Inflammation

Indexed keywords

C REACTIVE PROTEIN; HOMOCYSTEIC ACID; INTERLEUKIN 6; LIPID;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; BLOOD VESSEL DIAMETER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; INFLAMMATION; INTRAVASCULAR ULTRASOUND; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0032996676     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.7.1695     Document Type: Article

References (31)

1. Liuzzo G, Biasucci LM, Gallimore JR, Grille RL, Rebuzzi AG, Pepys MB, Maseri A. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994;331: 417-424.
2. Harverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MG. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action in Thrombolysis and Disabilities Angina Pectoris Study Group. Lancet. 1997;349:462-466.
3. Kuller LH, Tracy RP, Shaten J, Meinhahn EN. Relation of C-reactive protein and coronary artery disease in the MRFIT nested case-control study. Am J Epidemiol. 1996;144:537-547.
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and risks of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336:973-979.
5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97:425-428.
6. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vase Biol. 1997;17:1121-1127.
7. Biasucci LM, Vitelli A, Liuzzo G, Altamura S, Caligiuri G, Monaco C, Rebuzzi AG, Ciliberto G, Maseri A. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996;94:874-877.
8. Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjälä H, Airaksinen J, Leinonen M, Saikku P, Juvonen T. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. 1997;17:2843-2847.
9. Szekanecz Z, Shan MR, Pearce WH, Koch AE. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions. 1994;42: 159-162.
10. Pedersen OM, Aslaken A, Vik-Mo H. Ultrasound measurement of the luminal diameter of the abdominal aorta and iliac arteries in patients without vascular disease. J Vasc Surg. 1993;17:596-601.
11. Stampfer MJ, Sacks FM, Salvini S, Willet WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
12. Ridker PM, Hennekens CH, Selhub J, Miletich JP, Malinow MR, Stampfer MJ. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. Circulation. 1997;95:1777-1782.
13. Ridker PM, Hennekens CH, Stampfer MJ. A prospective study of lipoprotein(a) and the risk of myocardial infarction. JAMA. 1993;270: 2195-2199.
14. Navab, Liao F, Hough GP, Ross LA, Vanhentel BJ, Rajavashisth TB, Lusis AJ, Lacks H, Drinkwater DC, Folgeman AM. Interaction of monocytes with cocultures of human aortic wall cells involves interleukin-1 and -6 with marked increase in connexin-43 message. J Clin Invest. 1991;87:1763-1772.
15. Freestone T, Tuner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vase Biol. 1995;15:1145-1151.
16. Davies MJ. Aortic aneurysm formation: lessons from human studies and experimental models. Circulation. 1998;98:193-195.
17. McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearol WH. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vasc Biol. 1995;15:1139-1144.
18. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi Rh, Nagase H, Tilson MD. Identification of matrix metalloproteinase-3 (stromelysin-1) and 9 (gelatinase-B) in abdominal aortic aneurysm. Arterioscler Thromb Vase Biol. 1994;14:1315-1320.
19. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest. 1995;96:318-326.
20. McMillan WD, Tamarina N, Cipollone M, Johnson DA, Parker MA, Pearce WH. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation. 1997;96:2228-2232.
21. Allaire E, Hasenstab D, Kenagy RD, Starcher B, Clowes MM, Clowes AW. Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1. Circulation. 1998;98:249-255.
22. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson FW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1991;332:1149-1155.
23. Malinow MR, Kang SS, Taylor LM, Wong PW, Coull B, Inahara T, Mukerjee D, Sexton G, Upson B. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation. 1989;79:1180-1188.
24. Robinson K, Arheart K, Refium H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Mcleady R, Daly L, Witteman J, Graham I. Low circulating folate and vitamin B6 concentration: risk for stroke, peripheral vascular disease and coronary artery disease: European COMAC Group. Circulation. 1998;97:437-443.
25. Colwell N, Clarke R, Robinson K, Keane F, O'Briain S, Graham I. Hyperhomocysteinaemia and multiple aneurysms. Postgrad Med J. 1991; 67:186-188.
26. Starkebaum G, Harlan W. Endothelial cell injury due to cooper-catalyzed hydrogen peroxide generation form homocysteine. J Clin Invest. 1986; 77:1370-1376.
27. Berman RS, Martin W. Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system. Br J Pharmacol. 1993;108:920-926.
28. Nishinaga M, Ozawa T. Shimada K. Homocysteine, athrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultures porcine aortic endothelial cells. J Clin Invest. 1993;92:1381-1386.
29. Heinecke JW, Rosen H, Suzuki LA, Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem. 1987; 262:10098-10103.
30. Bauserman LL, Santelli AL, Van Zunden P, Gollaher CJ, Herbert PN. Degradation of serum amyloid A by isolated perfused rat liver. J Biol Chem. 1987;262:1583-1589.
31. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littoy FN, Bandyk D, Krupski WC, Barone GW, Archer CW, Ballard DJ. Prevalence and associations of abdominal aortic aneurysm detected through screening. Ann Intern Med. 1997;126:441-449.